PLP1 Gene Pelizaeus-Merzbacher disease Genetic Test
At DNA Labs UAE, we offer the PLP1 Gene Pelizaeus-Merzbacher disease Genetic Test to diagnose this rare genetic disorder affecting the central nervous system. This test can help identify mutations or variations in the PLP1 gene responsible for Pelizaeus-Merzbacher disease (PMD).
Test Details
Pelizaeus-Merzbacher disease (PMD) is characterized by abnormal myelin formation in the brain, leading to neurological symptoms such as impaired motor skills, muscle weakness, and cognitive impairment. Our Next-generation sequencing (NGS) technology allows for the simultaneous analysis of multiple genes, including the PLP1 gene associated with PMD.
Test Components and Price
- Test Name: PLP1 Gene Pelizaeus-Merzbacher disease Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on FTA Card for this test.
Report Delivery
You can expect to receive your test results within 3 to 4 weeks.
Test Type and Department
This test falls under the category of Neurological Disorders and is conducted by our Genetics department.
Referring Doctor
This test is recommended by Neurologists who specialize in neurological disorders.
Pre Test Information
Prior to the PLP1 Gene Pelizaeus-Merzbacher disease Genetic Test, we recommend providing the clinical history of the patient. Additionally, a Genetic Counselling session is conducted to draw a pedigree chart of family members affected by PMD.
Why Choose NGS Genetic Testing for PMD?
Next-generation sequencing (NGS) technology allows for a comprehensive analysis of the PLP1 gene, which can provide valuable information for diagnosing PMD and determining the specific genetic cause of the disease. This information is crucial for genetic counseling, family planning, and guiding potential treatment options.
Important Note
It is essential to have the PLP1 Gene Pelizaeus-Merzbacher disease Genetic Test performed by a qualified healthcare professional or genetic counselor. They can interpret the results accurately and provide appropriate guidance and support.
| Test Name | PLP1 Gene Pelizaeus-Merzbacher disease Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PLP1 Gene Pelizaeus-Merzbacher disease NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLP1 Gene Pelizaeus-Merzbacher disease |
| Test Details |
The PLP1 gene is associated with Pelizaeus-Merzbacher disease (PMD), which is a rare genetic disorder that affects the central nervous system. PMD is characterized by abnormal myelin formation in the brain, leading to neurological symptoms such as impaired motor skills, muscle weakness, and cognitive impairment. Next-generation sequencing (NGS) is a genetic testing technique that allows for the simultaneous analysis of multiple genes, including the PLP1 gene. NGS can detect mutations or variations in the PLP1 gene that may be responsible for PMD. NGS-based genetic testing for PMD involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the PLP1 gene. The results of the NGS genetic test can provide valuable information for diagnosing PMD and determining the specific genetic cause of the disease. This information can be used for genetic counseling, family planning, and potentially guiding treatment options. It is important to note that genetic testing for PMD should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support. |
